Company Celyad Oncology SA OTC Markets

Equities

CYADY

US1512052002

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Biotechnology & Medical Research

Inactive Instrument

Celyad Oncology SA is a biotechnology company focused on the discovery and development of innovative technologies chimeric antigen receptor (CAR) T-cell therapies. The company is focusing on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property and support the development of next-generation CAR T candidates in solid tumors and hematological malignancies.

Number of employees: 18

EUR in Million	2022	Weight	2023	Weight	Delta
Cardiology 100.0 %	0	nan %	0	100.0 %	-

EUR in Million	2022	Weight	2023	Weight	Delta
Europe and United States 100.0 %	0	nan %	0	100.0 %	-

Managers	Title	Age	Since
Michel Lussier FOU	Founder	67	07-07-23
David Georges DFI	Director of Finance/CFO	-	18-12-31
Eytan Breman CTO	Chief Tech/Sci/R&D Officer	-	14-12-31
An Phan LAW	General Counsel	49	21-08-31

Members of the board	Title	Age	Since
Michel Lussier FOU	Founder	67	07-07-23
Hilde Windels CHM	Chairman	59	18-05-06
Serge Goblet BRD	Director/Board Member	-	07-12-31
J. Christopher LiPuma BRD	Director/Board Member	53	22-01-19
Jonathan M. James BRD	Director/Board Member	-	-
Dominic Piscitelli BRD	Director/Board Member	50	20-05-05
Sage Mandel BRD	Director/Board Member	-	-
Marina Udier BRD	Director/Board Member	-	11-01-10
Ami Patel Shah BRD	Director/Board Member	-	21-12-07

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	41,428,572	38,267,083 ( 92.37 %)	0	92.37 %

Name	Equities	%	Valuation
Tolefi SA 5.541 %	2,295,701	5.541 %	797 779 $
Michel Lussier 0.3779 %	156,550	0.3779 %	54 403 $
OP Asset Management Ltd. 0.2571 %	106,527	0.2571 %	37 019 $
C Worldwide Asset Management Fondsmæglerselskab A/S (Sweden) 0.1840 %	76,235	0.1840 %	26 492 $
BNP Paribas Asset Management Belgium SA 0.1753 %	72,641	0.1753 %	25 243 $
Serge Goblet 0.1356 %	56,180	0.1356 %	19 523 $
Ecofi Investissements SA 0.0818 %	33,899	0.0818 %	11 780 $
Claresco Finance SA 0.0791 %	32,789	0.0791 %	11 395 $
Gestys SA 0.0676 %	28,000	0.0676 %	9 730 $
Puilaetco Dewaay Private Bankers SA 0.0394 %	16,313	0.0394 %	5 669 $

Celyad Oncology SA

Axis Business Park Rue André Dumont 9

1435, Mont-Saint-Guibert

+32 1 039 41 00

http://www.celyad.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+29.77%	49.46B
IQVIA HOLDINGS INC.	+1.00%	42.58B
LONZA GROUP AG	+49.39%	42.49B
CELLTRION, INC.	-5.26%	29.09B
ICON PUBLIC LIMITED COMPANY	+13.68%	26.61B
ALNYLAM PHARMACEUTICALS, INC.	-22.99%	18.64B
BIO-TECHNE CORPORATION	+8.22%	13.16B
MEDPACE HOLDINGS, INC.	+32.41%	12.55B
UNITED THERAPEUTICS CORPORATION	+24.01%	12.1B

Other Biotechnology & Medical Research